Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
12 2월 2025 - 10:45AM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G dated February 11, 2025 relating to the Common Stock, par value $0.001 per share, of Marinus Pharmaceuticals, Inc. shall
be filed on behalf of the undersigned.
|
SUVRETTA CAPITAL MANAGEMENT, LLC
By: /s/ Aaron Cowen |
|
Name: Aaron Cowen |
|
Title: Authorized Signatory |
|
AVERILL MASTER FUND, LTD.
By: /s/ Aaron Cowen |
|
Name: Aaron Cowen |
|
Title: Director |
|
AARON COWEN
By: /s/ Aaron Cowen |
Exhibit B
CONTROL PERSON IDENTIFICATION
Suvretta Capital Management, LLC is the relevant entity for which
Aaron Cowen is the control person.
Marinus Pharmaceuticals (NASDAQ:MRNS)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Marinus Pharmaceuticals (NASDAQ:MRNS)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025